Clinical characteristic | Number of patients (%) |
---|---|
Gender | |
 Male | 593 (45.6) |
 Female | 707 (54.4%) |
Age at diagnosis | |
 Median (range) | 63 (19–90) |
Tumor type | |
 Colorectal | 354 (27.2%) |
 Lung | 223 (17.2%) |
 Breast | 172 (13.2%) |
 Prostate | 83 (6.4%) |
 Melanoma | 65 (5%) |
 Lymphoma | 49 (3.8%) |
 Gastric | 45 (3.5%) |
 Head and neck | 45 (3.5%) |
 Bladder | 38 (2.9%) |
 Ocular melanoma | 32 (2.5%) |
 Endometrial | 29 (2.2%) |
 Kidney | 28 (2.2%) |
 Ovary | 24 (1.8%) |
 Brain | 24 (1.8%) |
 Oesophagus | 22 (1.7%) |
 Pancreas | 19 (1.5%) |
 Liver | 16 (1.2%) |
 Testis | 16 (1.2%) |
 Thyroid | 13 (1%) |
 Sarcoma | 3 (0.2%) |
Origin of the tumors | |
 Primary tumor | 1166 (89.7%) |
 Metastasis | 44 (3.4%) |
 Unknown | 90 (6.9%) |